Decision Diagnostics Corp. (DECN)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 1, 2025
Decision Diagnostics Revenue
Decision Diagnostics had revenue of $518.51K in the quarter ending September 30, 2021, with 42.89% growth. This brings the company's revenue in the last twelve months to $2.13M, down -3.07% year-over-year. In the year 2020, Decision Diagnostics had annual revenue of $1.98M, down -16.82%.
Revenue (ttm)
2.13M
Revenue Growth
-3.07%
P/S Ratio
0.00
Revenue / Employee
266.31K
Employees
8
Market Cap
380.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 1.98M | -400.08K | -16.82% |
| Dec 31, 2019 | 2.38M | 143.25K | 6.41% |
| Dec 31, 2018 | 2.24M | 355.60K | 18.91% |
| Dec 31, 2017 | 1.88M | 787.55K | 72.06% |
| Dec 31, 2016 | 1.09M | 577.85K | 112.20% |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Decision Diagnostics News
- 4 years ago - DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm - Newsfile Corp
- 4 years ago - DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm - Newsfile Corp
- 4 years ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN - Newsfile Corp
- 4 years ago - DECN FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – DECN - GlobeNewsWire
- 4 years ago - TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm - Newsfile Corp
- 4 years ago - Decision Diagnostics Shareholder Alert - Newsfile Corp
- 4 years ago - TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm - Newsfile Corp
- 4 years ago - DECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Decision Diagnostics Corp. - GlobeNewsWire